Do analysts prefer BRTX or ATPC?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Biorestorative Therapies 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Agape ATP 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Do analysts rate ATPC or BMGL?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Agape ATP 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Basel Medical Group 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has preferable earnings & valuation, ATPC or BMGL?

Agape ATP has higher earnings, but lower revenue than Basel Medical Group. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Agape ATP $1.52M 1.73 -$2.28M -$1.33 N/A Basel Medical Group $8.90M 1.08 -$9.50M N/A N/A

Does the media prefer ATPC or BMGL?

In the previous week, Basel Medical Group had 5 more articles in the media than Agape ATP. MarketBeat recorded 7 mentions for Basel Medical Group and 2 mentions for Agape ATP. Agape ATP's average media sentiment score of 0.93 beat Basel Medical Group's score of 0.61 indicating that Agape ATP is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Agape ATP 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Basel Medical Group 1 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts recommend ATPC or ADVB?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Agape ATP 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Advanced Biomed 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Do analysts recommend ACON or ATPC?

Aclarion presently has a consensus price target of $7.50, indicating a potential upside of 178.81%. Given Aclarion's stronger consensus rating and higher possible upside, analysts clearly believe Aclarion is more favorable than Agape ATP. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Aclarion 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Agape ATP 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has better earnings and valuation, ACON or ATPC?

Agape ATP has higher revenue and earnings than Aclarion. Agape ATP is trading at a lower price-to-earnings ratio than Aclarion, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Aclarion $80K 82.72 -$7.23M -$9.03 N/A Agape ATP $1.52M 1.73 -$2.28M -$1.33 N/A

Is ACON or ATPC more profitable?

Agape ATP has a net margin of -125.89% compared to Aclarion's net margin of -10,320.51%. Agape ATP's return on equity of -8.43% beat Aclarion's return on equity. Company Net Margins Return on Equity Return on Assets Aclarion -10,320.51% -54.41% -51.71% Agape ATP -125.89% -8.43% -7.75%

Does the media favor ACON or ATPC?

In the previous week, Aclarion had 2 more articles in the media than Agape ATP. MarketBeat recorded 4 mentions for Aclarion and 2 mentions for Agape ATP. Aclarion's average media sentiment score of 0.96 beat Agape ATP's score of 0.93 indicating that Aclarion is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Aclarion 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Agape ATP 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts prefer MGRX or ATPC?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Mangoceuticals 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Agape ATP 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Is MGRX or ATPC more profitable?

Agape ATP has a net margin of -125.89% compared to Mangoceuticals' net margin of -4,639.13%. Agape ATP's return on equity of -8.43% beat Mangoceuticals' return on equity. Company Net Margins Return on Equity Return on Assets Mangoceuticals -4,639.13% -112.00% -104.96% Agape ATP -125.89% -8.43% -7.75%

Does the media prefer MGRX or ATPC?

In the previous week, Mangoceuticals and Mangoceuticals both had 2 articles in the media. Mangoceuticals' average media sentiment score of 1.23 beat Agape ATP's score of 0.93 indicating that Mangoceuticals is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Mangoceuticals 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Agape ATP 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Agape ATP (ATPC) Competitors

$2.63 -0.09 (-3.31%)

Closing price 07/13/2026 04:00 PM Eastern

Extended Trading

$2.63 0.00 (0.00%)

As of 04:31 AM Eastern

Compare

ATPC vs. BRTX, BMGL, ADVB, ACON, and MGRX

Should you buy Agape ATP stock or one of its competitors? MarketBeat compares Agape ATP with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Agape ATP include Biorestorative Therapies (BRTX), Basel Medical Group (BMGL), Advanced Biomed (ADVB), Aclarion (ACON), and Mangoceuticals (MGRX). These companies are all part of the "healthcare" industry.

How does Agape ATP compare to Biorestorative Therapies?

Biorestorative Therapies (NASDAQ:BRTX) and Agape ATP (NASDAQ:ATPC) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their dividends, media sentiment, risk, institutional ownership, earnings, profitability, valuation and analyst recommendations.

In the previous week, Agape ATP had 1 more articles in the media than Biorestorative Therapies. MarketBeat recorded 2 mentions for Agape ATP and 1 mentions for Biorestorative Therapies. Biorestorative Therapies' average media sentiment score of 1.87 beat Agape ATP's score of 0.93 indicating that Biorestorative Therapies is being referred to more favorably in the media.

Company	Overall Sentiment
Biorestorative Therapies	Very Positive
Agape ATP	Positive

Biorestorative Therapies has a beta of 0.73, suggesting that its stock price is 27% less volatile than the broader market. Comparatively, Agape ATP has a beta of 0.31, suggesting that its stock price is 69% less volatile than the broader market.

Agape ATP has a net margin of -125.89% compared to Biorestorative Therapies' net margin of -3,088.27%. Agape ATP's return on equity of -8.43% beat Biorestorative Therapies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Biorestorative Therapies	-3,088.27%	-508.42%	-230.94%
Agape ATP	-125.89%	-8.43%	-7.75%

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Biorestorative Therapies	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Agape ATP	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Agape ATP has higher revenue and earnings than Biorestorative Therapies. Agape ATP is trading at a lower price-to-earnings ratio than Biorestorative Therapies, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Biorestorative Therapies	$360K	23.94	-$14.24M	-$1.07	N/A
Agape ATP	$1.52M	1.73	-$2.28M	-$1.33	N/A

69.4% of Biorestorative Therapies shares are held by institutional investors. Comparatively, 0.0% of Agape ATP shares are held by institutional investors. 13.6% of Biorestorative Therapies shares are held by insiders. Comparatively, 2.0% of Agape ATP shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Summary

Biorestorative Therapies beats Agape ATP on 7 of the 13 factors compared between the two stocks.

How does Agape ATP compare to Basel Medical Group?

Agape ATP (NASDAQ:ATPC) and Basel Medical Group (NASDAQ:BMGL) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their media sentiment, institutional ownership, valuation, earnings, risk, dividends, profitability and analyst recommendations.

In the previous week, Basel Medical Group had 5 more articles in the media than Agape ATP. MarketBeat recorded 7 mentions for Basel Medical Group and 2 mentions for Agape ATP. Agape ATP's average media sentiment score of 0.93 beat Basel Medical Group's score of 0.61 indicating that Agape ATP is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Agape ATP	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Basel Medical Group	1 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

0.0% of Agape ATP shares are owned by institutional investors. 2.0% of Agape ATP shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Agape ATP has a beta of 0.31, meaning that its share price is 69% less volatile than the broader market. Comparatively, Basel Medical Group has a beta of 0.15, meaning that its share price is 85% less volatile than the broader market.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Agape ATP	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Basel Medical Group	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Basel Medical Group has a net margin of 0.00% compared to Agape ATP's net margin of -125.89%. Basel Medical Group's return on equity of 0.00% beat Agape ATP's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Agape ATP	-125.89%	-8.43%	-7.75%
Basel Medical Group	N/A	N/A	N/A

Agape ATP has higher earnings, but lower revenue than Basel Medical Group.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Agape ATP	$1.52M	1.73	-$2.28M	-$1.33	N/A
Basel Medical Group	$8.90M	1.08	-$9.50M	N/A	N/A

Summary

Agape ATP beats Basel Medical Group on 6 of the 11 factors compared between the two stocks.

How does Agape ATP compare to Advanced Biomed?

Agape ATP (NASDAQ:ATPC) and Advanced Biomed (NASDAQ:ADVB) are both small-cap healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, dividends, valuation, risk, earnings, profitability, media sentiment and institutional ownership.

Agape ATP has a beta of 0.31, meaning that its share price is 69% less volatile than the broader market. Comparatively, Advanced Biomed has a beta of 0.52, meaning that its share price is 48% less volatile than the broader market.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Agape ATP	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Advanced Biomed	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Agape ATP has higher revenue and earnings than Advanced Biomed. Agape ATP is trading at a lower price-to-earnings ratio than Advanced Biomed, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Agape ATP	$1.52M	1.73	-$2.28M	-$1.33	N/A
Advanced Biomed	N/A	N/A	-$3.26M	$4.82	1.06

In the previous week, Agape ATP and Agape ATP both had 2 articles in the media. Agape ATP's average media sentiment score of 0.93 beat Advanced Biomed's score of 0.45 indicating that Agape ATP is being referred to more favorably in the media.

Company	Overall Sentiment
Agape ATP	Positive
Advanced Biomed	Neutral

0.0% of Agape ATP shares are owned by institutional investors. 2.0% of Agape ATP shares are owned by company insiders. Comparatively, 27.0% of Advanced Biomed shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Advanced Biomed has a net margin of 0.00% compared to Agape ATP's net margin of -125.89%. Advanced Biomed's return on equity of 87.74% beat Agape ATP's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Agape ATP	-125.89%	-8.43%	-7.75%
Advanced Biomed	N/A	87.74%	64.49%

Summary

Advanced Biomed beats Agape ATP on 7 of the 11 factors compared between the two stocks.

How does Agape ATP compare to Aclarion?

Aclarion (NASDAQ:ACON) and Agape ATP (NASDAQ:ATPC) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their dividends, institutional ownership, valuation, media sentiment, earnings, analyst recommendations, profitability and risk.

In the previous week, Aclarion had 2 more articles in the media than Agape ATP. MarketBeat recorded 4 mentions for Aclarion and 2 mentions for Agape ATP. Aclarion's average media sentiment score of 0.96 beat Agape ATP's score of 0.93 indicating that Aclarion is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Aclarion	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Agape ATP	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Aclarion presently has a consensus price target of $7.50, indicating a potential upside of 178.81%. Given Aclarion's stronger consensus rating and higher possible upside, analysts clearly believe Aclarion is more favorable than Agape ATP.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Aclarion	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Agape ATP	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Agape ATP has a net margin of -125.89% compared to Aclarion's net margin of -10,320.51%. Agape ATP's return on equity of -8.43% beat Aclarion's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Aclarion	-10,320.51%	-54.41%	-51.71%
Agape ATP	-125.89%	-8.43%	-7.75%

Aclarion has a beta of 1.21, meaning that its stock price is 21% more volatile than the broader market. Comparatively, Agape ATP has a beta of 0.31, meaning that its stock price is 69% less volatile than the broader market.

Agape ATP has higher revenue and earnings than Aclarion. Agape ATP is trading at a lower price-to-earnings ratio than Aclarion, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Aclarion	$80K	82.72	-$7.23M	-$9.03	N/A
Agape ATP	$1.52M	1.73	-$2.28M	-$1.33	N/A

7.5% of Aclarion shares are held by institutional investors. Comparatively, 0.0% of Agape ATP shares are held by institutional investors. 0.0% of Aclarion shares are held by insiders. Comparatively, 2.0% of Agape ATP shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Summary

Aclarion beats Agape ATP on 9 of the 16 factors compared between the two stocks.

How does Agape ATP compare to Mangoceuticals?

Mangoceuticals (NASDAQ:MGRX) and Agape ATP (NASDAQ:ATPC) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their risk, analyst recommendations, media sentiment, profitability, institutional ownership, earnings, valuation and dividends.

56.7% of Mangoceuticals shares are owned by institutional investors. Comparatively, 0.0% of Agape ATP shares are owned by institutional investors. 16.0% of Mangoceuticals shares are owned by company insiders. Comparatively, 2.0% of Agape ATP shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Agape ATP has higher revenue and earnings than Mangoceuticals. Agape ATP is trading at a lower price-to-earnings ratio than Mangoceuticals, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Mangoceuticals	$460K	13.44	-$20.64M	-$1.49	N/A
Agape ATP	$1.52M	1.73	-$2.28M	-$1.33	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Mangoceuticals	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Agape ATP	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Agape ATP has a net margin of -125.89% compared to Mangoceuticals' net margin of -4,639.13%. Agape ATP's return on equity of -8.43% beat Mangoceuticals' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Mangoceuticals	-4,639.13%	-112.00%	-104.96%
Agape ATP	-125.89%	-8.43%	-7.75%

In the previous week, Mangoceuticals and Mangoceuticals both had 2 articles in the media. Mangoceuticals' average media sentiment score of 1.23 beat Agape ATP's score of 0.93 indicating that Mangoceuticals is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Mangoceuticals	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Agape ATP	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Mangoceuticals has a beta of 2.28, suggesting that its stock price is 128% more volatile than the broader market. Comparatively, Agape ATP has a beta of 0.31, suggesting that its stock price is 69% less volatile than the broader market.

Summary

Mangoceuticals and Agape ATP tied by winning 6 of the 12 factors compared between the two stocks.

Get Agape ATP News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ATPC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

ATPC vs. The Competition

Export

Metric	Agape ATP	MED PRODUCTS Industry	Medical Sector	NASDAQ Exchange
Market Cap	$2.72M	$8.82B	$7.05B	$12.61B
Dividend Yield	N/A	2.54%	2.68%	8.00%
P/E Ratio	-1.98	16.09	27.13	24.26
Price / Sales	1.73	7.04	589.11	117.88
Price / Cash	N/A	18.40	29.22	49.36
Price / Book	0.12	3.57	10.77	6.29
Net Income	-$2.28M	$228.19M	$3.58B	$330.66M
7 Day Performance	-8.36%	-2.31%	-2.10%	-1.32%
1 Month Performance	-9.00%	-0.62%	3.29%	-0.64%
1 Year Performance	-96.17%	-2.73%	26.34%	19.08%

Agape ATP Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
ATPC Agape ATP	0.7004 of 5 stars	$2.63 -3.3%	N/A	-96.5%	$2.72M	$1.52M	N/A	40
BRTX Biorestorative Therapies	1.1416 of 5 stars	$0.35 -7.2%	N/A	-79.1%	$9.48M	$360K	N/A	7	Gap Down
BMGL Basel Medical Group	1.0482 of 5 stars	$6.22 +3.8%	N/A	-77.3%	$9.37M	$8.90M	N/A	36	News Coverage
ADVB Advanced Biomed	0.6198 of 5 stars	$5.04 -5.8%	N/A	N/A	$8.84M	N/A	1.05	40	Short Interest Increase Gap Down
ACON Aclarion	3.9586 of 5 stars	$2.95 -1.3%	$7.50 +154.2%	-62.6%	$7.36M	$80K	N/A	7	News Coverage Short Interest Decrease

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:ATPC) was last updated on 7/14/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Agape ATP (ATPC) Competitors

ATPC vs. BRTX, BMGL, ADVB, ACON, and MGRX

How does Agape ATP compare to Biorestorative Therapies?

Summary

How does Agape ATP compare to Basel Medical Group?

Summary

How does Agape ATP compare to Advanced Biomed?

Summary

How does Agape ATP compare to Aclarion?

Summary

How does Agape ATP compare to Mangoceuticals?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ATPC vs. The Competition

Agape ATP Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Agape ATP (ATPC) Competitors

ATPC vs. BRTX, BMGL, ADVB, ACON, and MGRX

How does Agape ATP compare to Biorestorative Therapies?

Does the media refer more to BRTX or ATPC?

Which has more risk and volatility, BRTX or ATPC?

Is BRTX or ATPC more profitable?

Do analysts prefer BRTX or ATPC?

Which has better valuation & earnings, BRTX or ATPC?

Do insiders & institutionals believe in BRTX or ATPC?

Summary

How does Agape ATP compare to Basel Medical Group?

Does the media prefer ATPC or BMGL?

Do institutionals and insiders have more ownership in ATPC or BMGL?

Which has more risk and volatility, ATPC or BMGL?

Do analysts rate ATPC or BMGL?

Is ATPC or BMGL more profitable?

Which has preferable earnings & valuation, ATPC or BMGL?

Summary

How does Agape ATP compare to Advanced Biomed?

Which has more risk and volatility, ATPC or ADVB?

Do analysts recommend ATPC or ADVB?

Which has stronger valuation and earnings, ATPC or ADVB?

Does the media prefer ATPC or ADVB?

Do insiders and institutionals hold more shares of ATPC or ADVB?

Is ATPC or ADVB more profitable?

Summary

How does Agape ATP compare to Aclarion?

Does the media favor ACON or ATPC?

Do analysts recommend ACON or ATPC?

Is ACON or ATPC more profitable?

Which has more risk & volatility, ACON or ATPC?

Which has better earnings and valuation, ACON or ATPC?

Do institutionals and insiders believe in ACON or ATPC?

Summary

How does Agape ATP compare to Mangoceuticals?

Do insiders and institutionals believe in MGRX or ATPC?

Which has preferable valuation & earnings, MGRX or ATPC?

Do analysts prefer MGRX or ATPC?

Is MGRX or ATPC more profitable?

Does the media prefer MGRX or ATPC?

Which has more risk & volatility, MGRX or ATPC?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ATPC vs. The Competition

Agape ATP Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools